CIBC Bancorp USA »

Ascendis Pharma AS shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 8.4k 266.72

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Flutter Entmt SHS (FLUT)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Micron Technology (MU)
Draftkings Com Cl A (DKNG)

View all positions for CIBC Bancorp USA

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS